Despite widespread recognition of pervasive patient safety problems in the U.S. health care system, research to develop feasible, scalable solutions has lagged, particularly in the ambulatory setting. The need for new approaches to improve safety is especially pressing in the care of ambulatory patients using high-risk immunosuppressive medications, as reports of preventable adverse events among this category of drugs have increased. To date, no studies have carefully defined the epidemiology of these safety risks. The proposed Advancing Safety Process Innovation Using Registries (ASPIRE) project will use advanced electronic health record (EHR) data analytics to define the magnitude of ambulatory patient safety errors and adverse events for patients receiving high risk medications (Aim 1). We will also characterize disparities in these risks across race/ethnicity, socioeconomic status, and medical complexity. Three categories of patient safety processes will be examined: 1) preventive practices that reduce adverse medication events, 2) safety monitoring for patients using high-risk immunosuppressive medications, and 3) management of abnormal results from medication toxicity monitoring. These findings will be used to inform the development of eMeasures, a new approach to quality measurement that uses automatically extracted EHR information to give clinicians and health systems information regarding specific patient safety problems (Aim 2). We will use eMeasurement standards, including the Quality Data Model (QDM), Health Quality Measures Format (HQMF) and other structured coded terminologies to develop, specify and test system-wide prototype eMeasures. HIT-solutions such as eMeasures that can be applied across EHR data repositories serve as a foundation for a continuous learning health care system, as envisioned by the Institute of Medicine. The work proposed here builds the groundwork for further testing and nationwide dissemination of eMeasures to monitor and improve safety for those using high-risk medications in the ambulatory setting.

Public Health Relevance

The ASPIRE project will use novel ways of analyzing data from electronic health records to study ambulatory patient safety errors and adverse events for patients receiving high-risk immunosuppressive medications. This information will be used to develop quality measures that are tailored to electronic health records (eMeasures) to monitor and reduce patient safety risks.

Agency
National Institute of Health (NIH)
Institute
Agency for Healthcare Research and Quality (AHRQ)
Type
Research Project (R01)
Project #
5R01HS024412-02
Application #
9147590
Study Section
Special Emphasis Panel (ZHS1-HSR-X (01))
Program Officer
Bartman, Barbara
Project Start
2015-09-30
Project End
2018-09-29
Budget Start
2016-09-30
Budget End
2017-09-29
Support Year
2
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94118
Li, Jing; Yazdany, Jinoos; Trupin, Laura et al. (2018) Capturing a Patient-Reported Measure of Physical Function Through an Online Electronic Health Record Patient Portal in an Ambulatory Clinic: Implementation Study. JMIR Med Inform 6:e31
Gianfrancesco, Milena A; Yazdany, Jinoos; Schmajuk, Gabriela (2018) The impact of smoking on disease measures in rheumatoid arthritis: the need for appropriate adjustment of time-varying confounding. Rheumatol Int 38:313-314
Tonner, Chris; Schmajuk, Gabriela; Yazdany, Jinoos (2017) A new era of quality measurement in rheumatology: electronic clinical quality measures and national registries. Curr Opin Rheumatol 29:131-137
Schmajuk, Gabriela; Yazdany, Jinoos (2017) Leveraging the electronic health record to improve quality and safety in rheumatology. Rheumatol Int 37:1603-1610
Schmajuk, Gabriela; Tonner, Chris; Trupin, Laura et al. (2017) Using health-system-wide data to understand hepatitis B virus prophylaxis and reactivation outcomes in patients receiving rituximab. Medicine (Baltimore) 96:e6528
Gianfrancesco, Milena A; Schmajuk, Gabriela; Haserodt, Sarah et al. (2017) Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety. Rheumatol Int 37:1611-1618
Wahl, Elizabeth R; Yazdany, Jinoos (2016) Challenges and Opportunities in Using Patient-reported Outcomes in Quality Measurement in Rheumatology. Rheum Dis Clin North Am 42:363-75
Schmajuk, Gabriela; Tonner, Chris; Miao, Yinghui et al. (2016) Folic Acid Supplementation Is Suboptimal in a National Cohort of Older Veterans Receiving Low Dose Oral Methotrexate. PLoS One 11:e0168369
Yazdany, Jinoos; Myslinski, Rachel; Miller, Amy et al. (2016) Methods for Developing the American College of Rheumatology's Electronic Clinical Quality Measures. Arthritis Care Res (Hoboken) 68:1402-9
Yazdany, Jinoos; Robbins, Mark; Schmajuk, Gabriela et al. (2016) Development of the American College of Rheumatology's Rheumatoid Arthritis Electronic Clinical Quality Measures. Arthritis Care Res (Hoboken) 68:1579-1590

Showing the most recent 10 out of 14 publications